Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids suppress the inflammatory response through multiple mechanisms. They restrain TH cell clonal proliferation, reduce IL-2 gene transcription, and decrease cytokine production. Additionally, they inhibit vasodilation and reduce mediator release from eosinophils, preventing the cascade of inflammatory events that characterize asthma progression.

Prominent inhaled corticosteroids include beclomethasone, budesonide, fluticasone, mometasone, ciclesonide, and triamcinolone. These compounds are FDA-indicated as the treatment of choice for preventing asthma symptoms in patients with persistent asthma. They effectively prevent chronic asthma progression and manage acute severe cases.

Spacers are attachments for metered-dose inhalers that optimize drug delivery by ensuring more medication reaches the lungs and less deposits in the mouth and throat. This targeted delivery directly to the bronchial mucosa enhances therapeutic efficacy and reduces local adverse effects from medication residue.

Potential adverse effects include oropharyngeal candidiasis (thrush), sore throat, croaky voice, and adrenal suppression at high doses. Risk mitigation involves using spacers and rinsing the mouth after inhalation to remove residual medication. Patients should use the lowest effective dose and ensure proper inhalation technique to minimize these effects.

Yes, consistent use of inhaled corticosteroids can significantly improve asthma symptoms and quality of life. For patients with severe asthma, inhaled corticosteroids may eliminate the need for oral glucocorticoids, which carry more systemic side effects. This makes inhaled corticosteroids a cornerstone of asthma management due to their efficacy and relative safety profile.

Inhaled corticosteroids precisely target the bronchial mucosa, the lining of the airways, delivering medication directly to inflammation sites. This targeted approach provides potent anti-inflammatory effects while minimizing systemic exposure and associated side effects compared to oral glucocorticoids, making them ideal for long-term asthma maintenance.

Inhaled corticosteroids are potent anti-inflammatory agents that address the underlying inflammation in asthma, unlike bronchodilators that provide symptom relief. While other antiasthma drugs like mast cell stabilizers and anti-IgE drugs target specific immune pathways, inhaled corticosteroids remain the first-line maintenance therapy for persistent asthma due to their broad anti-inflammatory mechanism.